Hiroyuki Uetake, MD

Articles by Hiroyuki Uetake, MD

UFT Plus Leucovorin for Metastatic Colorectal Cancer: Japanese Experience

ByWataru Ichikawa, MD, PhD,Zenro Nihei, MD, PhD,Hiroyuki Uetake, MD,Hiroyuki Yamada, MD,Yoshinori Shirota, MD,Kenichi Sugihara, MD, PhD

In the United States and Europe, the combination of oral UFT plus leucovorin has been reported to produce objective responses and survival rates similar to those achieved with standard intravenous 5-fluorouracil plus leucovorin in patients with metastatic colorectal cancer, with reduced toxicity.

Latest Updated Articles